Click on a filter below to refine your search. Remove a filter to broaden your search.
More than half (51.1%) of those with diabetes who used cannabis were aged more than 50 years.
KFF survey highlights states’ Medicaid eligibility, enrollment policies during unwinding … Amber Lights earns CARF re-accreditation … 2017 to 2022 saw rise in cannabis-related disorder encounters...
The budding shift in our nation’s drug policy could have notable implications for senior living operators — and the residents they serve.
A move by the federal government to reclassify marijuana as a schedule III drug could have implications for senior living residents.
The greatest rates were seen in states or territories with both adult and medical use legalization.
The findings persisted even after considering cigarette smoking, vaccination status, comorbidities and other risk factors.
The proportion of patient-reported qualifying conditions with substantial, conclusive evidence of therapeutic value decreased.
The findings show a dose-response relationship among US individuals 12 years and older.